The Community Guide

- gsearch

Search Results

Narrow Results:

2022 1
2017 1

California 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era

CITE Title : Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era Personal Author(s) : Tao, Li;Clarke, Christina A.;Rosenberg, Aaron S.;Advani, Ranjana H.;Jonas, Brian A.;Flowers, Christopher R.;Keegan, Theresa H.M.; Published Date : May 25 2017 Source : Br J Haematol. 178(1):72-80. URL : https://stacks.cdc.gov/view/cdc/46492 Tao, Li et al. (2017). Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era. 178(1). Tao, Li et al. "Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era" 178, no. 1 (2017) Tao, Li et al. "Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era" vol. 178, no. 1, 2017 Export RIS Citation Information.

:

Tao, Li ;

Clarke, Christina A.

May 25 2017 | Br J Haematol. 178(1):72-80.

:

With the addition of rituximab and other treatment advances, survival after diffuse large B-cell lymphoma (DLBCL) has improved, but subsequent primary...
Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors

CITE Title : Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors Personal Author(s) : Abrahão, Renata;Brunson, Ann M.;Kahn, Justine M.;Li, Qian W.;Wun, Ted;Keegan, Theresa H. M.; Published Date : 5 2022 Source : Leuk Lymphoma. 63(5):1091-1101 URL : https://stacks.cdc.gov/view/cdc/121157 Abrahão, Renata et al. (2022). Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors. 63(5). Abrahão, Renata et al. "Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors" 63, no. 5 (2022) Abrahão, Renata et al. "Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors" vol. 63, no. 5, 2022 Export RIS Citation Information.

:

Abrahão, Renata ;

Brunson, Ann M.

5 2022 | Leuk Lymphoma. 63(5):1091-1101

:

We compared secondary primary malignancy risk (SPM) in HIV-uninfected and HIV-infected Hodgkin lymphoma (HL) survivors. We used data from the Californ...